Study of UBT251 injection for type 2 diabetes not controlled by diet and exercise
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a new injected drug (UBT251) for people with type 2 diabetes who haven't been able to control their blood sugar with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with type 2 diabetes for at least 3 months.
- You have been managing your diabetes with only diet and exercise (no diabetes pills or insulin) for the past 3 months.
- Your HbA1c (average blood sugar over 3 months) is between 7.5% and 10.5%.
- Your body mass index (BMI) is 23 or higher and your weight has been stable (not changed more than 5%) for the last 3 months.
- You are not pregnant or planning pregnancy, and you agree to use reliable birth control during the study and for 6 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called UBT251 for people with type 2 diabetes whose blood sugar is not well controlled despite taking metformin, either alone or with another diabetes medicine. The goal is to see if it can lower blood sugar levels more than a placebo.
This trial tests an investigational drug called GUB-UCN2 in people who are healthy, overweight, or have type 2 diabetes. The goal is to see if the drug is safe and how the body processes it.
This study tests an investigational drug called HS-20094 to see how well it controls blood sugar in people with type 2 diabetes. It may help you manage your diabetes better if diet and exercise alone are not enough.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.
This study tests a new medicine called HS-20094 for people with type 2 diabetes. It aims to see if it helps lower blood sugar and may also help with weight. You may be able to join if you are currently on metformin or metformin plus an SGLT-2 inhibitor.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.